The outcome of a trial published in Science Translational Medicine, shows encouraging results for a new vaccine targeting group B meningococcus (MenB), a significant cause of meningococcal disease ...

Neisseria meningitidis, also called meningococcus, is the most common cause of bacterial meningitis in children and teens. In adults, it's the second most common cause. In many people, the ...

Some types of bacterial meningitis can be prevented through immunizations. There are vaccines that protect against pneumococcus, meningococcus, and Hib, all of which cause meningitis. Vaccinations ...

For most, it’s a life-changing illness. Meningococcal disease is caused by the meningococcus bacteria, also known as Neisseria meningitidis. The bacterial infection causes meningitis (infection ...

Vaccinations against meningococcal C bacteria are recommended for everyone ... A local vaccination campaign against meningococcus B was launched. It involved around 30,000 children between the ...

The ministry of health has issued statements explaining that the meningococcus bacteria spreads through close contact, typically via respiratory droplets. The risk is particularly high for those ...

The winter of 2022-2023 has seen a resurgence of acute meningitis, specifically those caused by bacteria called meningococcus. JAMES CAVALLINI/PHOTO RESEARCHERS/BIOSPHOTO In addition to the triple ...

The ministry of health has issued statements explaining that the meningococcus bacteria spreads through close contact, typically via respiratory droplets. The risk is particularly high for those ...

recommended by the World Health Organization (WHO), which protects people against five strains of the meningococcus bacteria. The vaccine and emergency vaccination activities are funded by Gavi ...

The world health body, in a statement on Friday, said that the vaccine would protect people against five strains of meningococcus bacteria, and described Nigeria’s feat as historic. It said that ...

The Men5CV vaccine protects people against five strains of the meningococcus bacteria. Claudia Hammond is joined by New Scientist medical journalist Clare Wilson to discuss how it’s hoped the ...